Your Joint OptionsFind my next step

Medically reviewed by Charles A. DeCook, MD ·

← All options
Established care

Topical anti-inflammatory

Rub-on pain relief for the knee.

01

What could it help with?

An anti-inflammatory gel can ease knee pain with less whole-body exposure than an oral NSAID. It is still a medicine, with dose limits and interactions. [1][2]

02

Who might it suit?

For: Knee pain when an anti-inflammatory is safe for you.

Not for: People with NSAID contraindications; not a first-line treatment for a deep hip joint.

03

Limits and important cautions

A deep hip joint is less suited to topical treatment. Skin reactions and NSAID contraindications still matter; check other medicines with your clinician.

What happens, how long, and what could it cost?
What happens
Review medicines, health conditions, contraindications, and the exact dose with your clinician or pharmacist.
When might I notice a change?
Timing depends on the medicine and formulation; follow its label and prescribed plan.
How long might benefit last?
Symptom control varies. Ask how long to try it before reviewing the result.
Repeat treatment
Review ongoing need and adverse effects. Do not abruptly stop prescribed opioids.
Activity and recovery
Ask about driving, interactions, and activities affected by the specific medicine.
Ask for a complete estimate
Medicine, visits, and any necessary monitoring.

Use this as a consultation guide. A timeline is not a guarantee; the evidence and FDA sections below remain part of the decision.

Compare expectations side by side ↗

THE EVIDENCE IN CONTEXT

Guideline-supported for knee OA

Read the 2 selected references
  1. ACR/Arthritis Foundation: OA management ↗Clinical guideline · 2020

    2019 guideline, published in 2020. Recommendations vary by joint; it predates many newer trials.

  2. NICE NG226: osteoarthritis care ↗Clinical guideline · 2022

    UK guidance on exercise, medicines, supports, and referral. Recommendations are not US coverage rules.

Editorial synthesis · reviewed September 19, 2026. These are selected decision-relevant references, not an exhaustive systematic review or a new formal evidence grade. FDA status and coverage are assessed separately.

FDA status

Approved products · follow the label

Approved diclofenac gel products exist; follow the specific product label.

Site summary of FDA information · reviewed September 19, 2026. Refer to current product labeling. This is not an FDA endorsement of this site.
What do professional guidelines say?

AAOS: Strong recommendation for topical NSAIDs for knee OA when not contraindicated.

ACR: Strongly recommends topical NSAIDs for knee OA.

Will Medicare cover it?

Coverage depends on medical need, product, provider, and plan. Confirm before care.

How we interpret changing evidence